David Kerr

David Kerr

  • dkerr at bournemouth dot ac dot uk
Back to top

Journal Articles

  • Bowes, A., Hale, A., Haviland, J. and Kerr, D., 2013. Obesity trends in people with Type 1 diabetes are the same as for the general UK population. DIABETIC MEDICINE, 30, 105.
  • Little, S., Kerr, D. et al., 2012. Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial). BMC Endocrine Disorders, 12.
  • Boyle, J., Eriksson, M.E.V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D.V. and Kerr, D., 2012. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 35 (12), 2451-2458.
  • Boyle, J., Eriksson, M.E.V., Gribble, L., Gouni, R., Johnsen, S., Coppini, D.V. and Kerr, D., 2012. Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain. DIABETES CARE, 35 (12), 2451-2458.
  • Naik, S., Kerr, D., Begley, J. and Morton, J., 2012. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study. Diabetes Technol Ther, 14 (11), 1018-1022.
  • Marden, S., Thomas, P.W., Sheppard, Z.A., Knott, J., Lueddeke, J. and Kerr, D., 2012. Poor numeracy skills are associated with glycaemic control in Type 1 diabetes. Diabet Med, 29 (5), 662-669.
  • Kerr, D., Partridge, H., Knott, J. and Thomas, P.W., 2011. HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes. Diabet Med, 28 (12), 1520-1524.
  • Kerr, D., Messing, R. and Resch, A., 2011. Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy. J Diabetes Sci Technol, 5 (6), 1584-1590.
  • Rana, O., Byrne, C.D., Kerr, D., Coppini, D.V., Zouwail, S., Senior, R., Begley, J., Walker, J.J. and Greaves, K., 2011. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation, 124 (14), 1548-1556.
  • Kerr, D. and Partridge, H., 2011. Deus ex machina: the use of technology in type 1 diabetes. Prim Care Diabetes, 5 (3), 159-165.
  • Choudhary, P., Shin, J., Wang, Y., Evans, M.L., Hammond, P.J., Kerr, D., Shaw, J.A.M., Pickup, J.C. and Amiel, S.A., 2011. Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia Reduction in nocturnal hypoglycemia in those at greatest risk. DIABETES CARE, 34 (9), 2023-2025.
  • Collins, A., Cortes, N., Matthews, B.N., Kerr, D. and McCormick, R., 2011. Reversible blindness: severe pneumococcal induced uveitis following septicaemia. BMJ Case Rep, 2011.
  • Rana, O., Kerr, D., Zouwail, S., Coppini, D.V., Begley, J., Byrne, C.D., Senior, R. and Greaves, K., 2010. The Effect of Insulin and Insulin-induced Hypoglycemia on Myocardial Blood Flow Reserve in Patients with Complicated Type 1 Diabetes Mellitus. CIRCULATION, 122 (21).
  • Kerr, D., 2010. Sensor-augmented insulin-pump therapy in type 1 diabetes [2]. New England Journal of Medicine, 363 (21), 2070-2071.
  • Kerr, D., Hoogma, R.P.L.M., Buhr, A., Petersen, B., Storms, F.E.M.G. and study investigators, 2010. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion. J Diabetes Sci Technol, 4 (6), 1400-1407.
  • Everett, J., Bowes, A. and Kerr, D., 2010. Barriers to improving glycaemic control in CSII. Journal of Diabetes Nursing, 14 (5), 176-181.
  • Sims, J., Richardson, T. and Kerr, D., 2010. Insulin errors in hospital: Time for a radical. Clinical Risk, 16 (3), 89-92.
  • Eriksson, M., Coppini, D., Gouni, R., Kerr, D., Knight, R. and Boyle, J., 2010. CLINICAL SLEEP VARIABLES IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY. SLEEP, 33, A289.
  • Hammond, P.J., Amiel, S.A., Dayan, C.M., Kerr, D., Pickup, J., Shaw, J.A.M., Campbell, F.M., Greene, S.A. and Hindmarsh, P.C., 2010. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Practical Diabetes International, 27, 66-68.
  • Everett, J. and Kerr, D., 2010. Telehealth as adjunctive therapy in insulin pump treated patients: a pilot study. Practical Diabetes International, 27, 9-10.
  • Rossi, M., Kerr, D. et al., 2010. Diabetes Interactive Diary: A New Telemedicine System Enabling Flexible Diet and Insulin Therapy While Improving Quality of Life. An open-label, international, multicenter, randomized study. Diabetes Care, 33, 109-115.
  • Todres, L., Keen, S. and Kerr, D., 2010. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of ‘living with a machine’. Diabetic Medicine, 27, 1201-1204.
  • Kerr, D. and Marden, S., 2010. Numeracy and insulin pump therapy. Diabetic Medicine, 27, 730-731.
  • Kerr, D. and Olateju, T., 2010. Pascal’s Wager: Combining continuous glucose monitoring and continuous subcutaneous insulin infusion. Diabetes Technology and Therapeutics.
  • Kerr, D. and Olateju, T., 2010. Driving with Diabetes in the Future: In-Vehicle Medical Monitoring. Journal of Diabetes Science and Technology, 4, 464-469.
  • Marden, S., Thomas, P., Knott, J. and Kerr, D., 2010. Numeracy and diabetes: the elephant in the room. Lancet.
  • Kerr, D. and Partridge, H., 2010. Deus Ex Machina. Use of technologies in diabetes care. Primary Care Diabetes.
  • Kerr, D., 2010. Wrath of Grapes. Diabetes Digest.
  • Kerr, D. and Bowes, A., 2010. Alcohol and Calories. Lancet.
  • Everett, J., Bowes, A. and Kerr, D., 2010. Barriers to improving control with CSII. Journal of Diabetes Nursing.
  • Sims, J., Richardson, T. and Kerr, D., 2010. Insulin errors in hospital: time for a radical re-think on risk? Clinical Risk, 16, 89-92.
  • Kerr, D., 2010. The Boy Done Good (Editorial). Diabetes Digest.
  • Todres, L., Keen, S. and Kerr, D., 2010. Continuous subcutaneous insulin infusion in type 1 diabetes: patient experiences of 'living with a machine'. Diabetic Medicine, 27, 1-5.
  • Kerr, D., 2010. Googled yourself lately? Your patients probably have. Diabetes Digest, 9.
  • Partridge, H. and Kerr, D., 2009. Advantages of insulin pump therapy: Letter: Original Observation. Diabetic Medicine, 26 (12), 1306.
  • Vespasiani, G., Kerr, D. et al., 2009. Comparison between the "Diabetes Interactive Diary" telemedicine system and standard carbohydrate counting education: an open label, international, multicentre, randomised study. DIABETOLOGIA, 52, S388.
  • Rana, O.A., Zouwail, S., Begley, J., Kerr, D., Coppini, D.V., Senior, R. and Greaves, K., 2009. The effect of hypoglycaemia on myocardial blood flow reserve and endothelin-1 levels in healthy non-diabetic subjects using myocardial contrast echocardiography. EUROPEAN HEART JOURNAL, 30, 457.
  • Hickish, T.F., Astras, G., Thomas, P., Penfold, S., Purandare, L. and Kerr, D., 2009. Glucose intolerance during adjuvant chemotherapy for breast cancer. Correspondence. Journal of the National Cancer Institute, 101, 537.
  • Kerr, D., 2009. Individualism and insulin pump therapy. Diabetologia, 52, 362.
  • Bolli, G.B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. and Home, P., 2009. Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study. Diabetes Care, 32, 1170-1176.
  • Partridge, H. and Kerr, D., 2009. Gastrointestinal upset following improvement of HbA1c on initiation of insulin pump therapy. Practical Diabetes International, 26, 14-15.
  • Cooke, D., Kerr, D. et al., 2009. Randomised controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin treated diabetes (MITRE study). Diabetic Medicine, 26, 540-547.
  • Richardson, T., Baker, J., Thomas, P.W., Meckes, C., Rozkovec, A. and Kerr, D., 2009. Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction. Quarterly Journal of Medicine, 102, 555-561.
  • Shaban, C., Fosbury, J., Cavan, D.A., Kerr, D. and Skinner, T., 2009. The relationship between generic and diabetes specific psychological factors and glycaemic control in adults with type 1 diabetes. Diabetes Research and Clinical Practice, 85, 26-29.
  • Kerr, D., Penfold, S., Zouwail, S., Thomas, P. and Begley, J.P., 2009. The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes. A pilot study. Quarterly Journal of Medicine, 102, 169-174.
  • Newman, S., Kerr, D. et al., 2009. A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technology Assessment., 13.
  • Partridge, H. and Kerr, D., 2009. Advantages of insulin pump therapy. Diabetic Medicine, 26, 1306.
  • Partridge, H. and Kerr, D., 2009. Letter: Original Observation. Advantages of insulin pump therapy. Diabetic Medicine, 26, 1306.
  • Kerr, D., 2009. Fiscal failures and corporate controversy. Diabetes Digest, 8.
  • Kerr, D., 2009. Addressing the imbalance of international diabetes care. Diabetes Digest, 8, 64.
  • Kerr, D., 2009. Thumbs up for NICE guidelines. Diabetes and Primary Care, 11, 138.
  • Kerr, D., 2009. Deus ex Machina. Diabetes Digest, 8, 186.
  • Kerr, D., 2009. The rocky, yet unremarkable road of media hype. Diabetes Digest, 8, 124.
  • Kerr, D. and Partridge, H., 2009. Smart insulin pump therapy: consumable costs and considerations. Infusystems International, 8, 9-12.
  • Fayers, K. and Kerr, D., 2009. CSII Pumps up the Volume of Approval. Diabetes Research and Clinical Practice.
  • Richardson, T., Baker, J., Thomas, P., Meakes, C., Rozkovec, R. and Kerr, D., 2009. Randomised controlled trial investigating the influence of coffee in patients with ST-segment elevation myocardial infarction. Quarterly Journal of Medicine, 102, 555-561.
  • Edmonds, M., European, Group, A.A.D.F.U.S. and Kerr, D., 2009. Apligraft in the treatment of neuropathic diabetic foot ulcers. International Journal of Lower Extremity Wounds, 8, 11-18.
  • Vespasiani, G., Kerr, D. et al., 2008. Comparison between the "Diabetes Interactive Diary" system and standard carbohydrate counting education: an open label, multicentre, randomised study. DIABETOLOGIA, 51, S101-S102.
  • Kerr, D., 2008. Continuous subcutaneos insulin infusion therapy and children with type 1 diabetes mellitus: The 2008 updated NICE guidelines. British Journal of Diabetes and Vascular Disease, 8 (SUPPL. 1).
  • Kerr, D., Nicholls, H. and James, J., 2008. Continuous subcutaneous insulin infusion (CSII insulin pump therapy) for type 1 diabetes: a Bournemouth perspective. Practical Diabetes International, 25, 114-117.
  • Kerr, D. and Bdiri, A., 2008. Quinine-associated hypoglycaemia causing diabetes. Diabetic Medicine, 25 (2), 241-242.
  • Goeke, B., Hershon, K., Kerr, D., Calle Pascual, A., Schweizer, A., Foley, J., Shao, S. and Dejager, S., 2008. Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug- Naïve Patients with Type 2 Diabetes: Comparison with Metformin. Hormone and Metabolic Research, 40, 892-895.
  • Kerr, D. and Fayers, K., 2008. Continuous real-time glucose monitoring systems: time for a closer look. Practical Diabetes International, 25, 37-41.
  • Kerr, D., 2008. A life in the day of Mrs W. Clinical Medicine: Journal of the Royal College of Physicians of London, 8, 515-516.
  • Penfold, S., Gouni, R., Hamilton, P., Richardson, T. and Kerr, D., 2008. Immediate in-patient management of hyperglycaemia: confusion rather than consensus? QJM, 101, 87-90.
  • Kerr, D., Morton, J., Whately-Smith, C., Everett, J. and Begley, J.P., 2008. Laboratory-Based Non-Clinical Comparison of Occlusion Rates Using Three Rapid-Acting Insulin Analogs in Continuous Subcutaneous Insulin Infusion Catheters Using Low Flow Rates. Journal of Diabetes Science and Technology, 2, 450-455.
  • Kerr, D., 2008. All change at the top (Editorial). Diabetes Digest, 7, 4.
  • Kerr, D., 2008. The forgotten few. Diabetes Digest, 7, 72.
  • Kerr, D., James, J. and Nicholls, H., 2008. Technologies as therapeutic devices. What do we expect from users of insulin pump therapy. Infusystems International, 7, 1-4.
  • Kerr, D., 2008. Review: Continuous Subcutaneous Insulin Infusion Therapy and Children with Type 1 Diabetes Mellitus: The 2008 Updated NICE Guidelines. British Journal of Diabetes and Vascular Disease, 8, S2-S5.
  • Kerr, D., 2008. The Tomato Effect. Diabetes Digest, 7, 140.
  • Kerr, D. and Bdiri, A., 2008. Letters: Quinine-associated hypoglycaemia causing diabetes. Diabetic Medicine, 25, 241-242.
  • James, J., Thomas, P. and Kerr, D., 2007. Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS). British Medical Journal, 335, 762-764.
  • Nicholls, H., Marden, S., Kerr, D. and Richardson, T., 2007. How should we be assessing glucose tolerance postpartum? DIABETIC MEDICINE, 24, 115.
  • Nicholls, H., Everett, J., Richardson, T. and Kerr, D., 2007. Insulin pumps, patients choose to keep it simple. DIABETIC MEDICINE, 24, 120.
  • Trowbridge, S., Cavan, D., Kerr, D. and Richardson, T., 2007. Is a care pathway for diabetes in the dying well received by the Palliative Care team? DIABETIC MEDICINE, 24, 69.
  • Trowbridge, S., Knott, J., Cavan, D., Richardson, T. and Kerr, D., 2007. Lifestyle improvement for everyone. Re-visiting lifestyle education before insulin initiation. DIABETIC MEDICINE, 24, 94.
  • Knott, J., James, J., Richardson, T., Cavan, D.A. and Kerr, D., 2007. Premature mortality following the diagnosis of Type 2: is it going in the right direction? DIABETIC MEDICINE, 24, 114.
  • Young, J.M., Kerr, D., Gouni, R. and Penfold, S., 2007. Response to treatment for painful diabetic neuropathy in a dedicated multidisciplinary clinic. DIABETIC MEDICINE, 24, 85.
  • Pandey, K., Sriraman, R., Kerr, D. and Richardson, T., 2007. Unprecipitated lactic acidosis in a patient on modified-release metformin. DIABETIC MEDICINE, 24, 108.
  • Kerr, D., 2007. Information in diabetes care: is there a need to dumb down even more? Diabetic Medicine, 24, 561-563.
  • Kerr, D., Cheyne, E.H., Thomas, P. and Sherwin, R.S., 2007. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabetic Medicine, 24, 312-316.
  • Kerr, D., 2007. The changing face of diabetes specialist services: making it work. Diabetes and Primary Care, 9, 99.
  • Kerr, D., Knott, J. and Cavan, D.A., 2007. The changing shape of type 2 diabetes. Practical Diabetes International, 24, 13-14.
  • Rosenthal, M.J., Smith, D., Yaguez, L., Giampietro, V., Kerr, D., Bullmore, E., Brammer, M., Williams, S.C.R. and Amiel, S.A., 2007. Caffeine restores regional brain activation in acute hypoglycaemia in healthy volunteers. Diabetic Medicine, 24, 720-727.
  • Heller, S.R. and Kerr, D., 2007. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia, 50, 1140-1147.
  • Richardson, T. and Kerr, D., 2007. Ergotamine use in severe diabetic autonomic neuropathy (Letter). Diabetic Medicine, 24, 103.
  • Kerr, D., 2007. Who’s taking what and is it the real thing? Diabetes Digest, 6, 4.
  • Kerr, D., 2007. Insulin initation in type 2 diabetes. More science than art. Diabetes Digest, 6, 140.
  • Kerr, D., 2007. A socialist, capitalist or pipe-and-slippers approach to diabetes research? Diabetes Digest, 6, 72.
  • Kerr, D., 2007. Laying the foundations of a QOF for specialist diabetes care. Diabetes Digest, 6, 208.
  • Miles, P., Kerr, D. and Richardson, T., 2007. Cutaneous problems in insulin therapy. MIMS Dermatology, 3, 14-15.
  • Kerr, D., 2006. I married a SEN. Nursing Times, Novermber 14.
  • Kar, P.S., Goonawardene, M. and Kerr, D., 2006. Emphysematous pyelonephritis: Early diagnosis results in avoidance of surgical intervention. Practical Diabetes International, 23 (4), 176.
  • Edmonds, M., Foster, A., Jemmott, T., Kerr, D., Malik, R., Knowles, A., Jude, E., Chadwick, P., Rahaman, L. and Murray, N., 2006. Kerraboot vs Allevyn for treating diabetic foot ulcers. Wounds UK, 2, 25-30.
  • Riveline, J.P., Kerr, D. et al., 2006. Improvement of the glycemic equilibrium in patients with diabetes type 1 using system of the continued evaluation of the glucose by reading the results in real-time: results of the Guardcontrol study. DIABETES & METABOLISM, 32, S15.
  • Hoogma, R.P.L.M., Kerr, D. et al., 2006. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabetic Medicine, 23, 141-147.
  • Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D. and Phillip, M., 2006. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care, 29, 2730-2732.
  • Evans, K.M., Kerr, D. and Flanagan, D.E.H., 2006. Diabetes and alcohol: time for realistic advice based on the evidence. Practical Diabetes International, 23, 267-272.
  • Kerr, D. and Richardson, T., 2006. Treating insulin allergy with continuous subcutaneous insulin infusion (CSII)(Letter). Diabetic Medicine, 23, 1159.
  • Shaban, M.C., Fosbury, J., Kerr, D. and Cavan, D.A., 2006. The prevalence of depression and anxiety in adults with Type 1 diabetes. Diabetic Medicine, 23, 1381-1384.
  • Cavan, D.A., Kerr, D. and Everett, J., 2006. Warning worries (Letter). Balance.
  • Kerr, D., 2006. Shifting care to the community: the political punch of Richard & Judy. Diabetes Digest, 5, 4.
  • Kerr, D., 2006. Changing diabetes care on a cosmological scale. Diabetes Digest, 5, 72.
  • Kerr, D., 2006. Data equals power. Ensuring medicines do what they say on the tin. Diabetes Digest, 5, 130.
  • Kerr, D., 2006. More emphasis on the first two Rs, less on the third please! Diabetes Digest, 5, 210.
  • Kar, P.S., Goonawardene, M. and Kerr, D., 2006. Diabetes vignette: emphysematous pyelonephritis: early diagnosis results in avoidance of surgical intervention. Practical Diabetes International, 23, 176.
  • Kerr, D., 2005. Overweight children and adolescents (Letter). New England Journal of Medicine, 353, 1070-1071.
  • Ludwig, D.S., Ebbeling, C.B., Kerr, D., Dietz, W.H. and Robinson, T.N., 2005. Overweight children and adolescents [5] (multiple letters). New England Journal of Medicine, 353 (10), 1070-1071.
  • Kerr, D., 2005. As fit as a butcher's dog. Lancet, 365 (9475), 1981.
  • Trowbridge, S. and Kerr, D., 2005. Opening Pandora's box: Home assessments for people with diabetes are revealing. Practical Diabetes International, 22 (1), 32.
  • Richardson, T., Weiss, M.J., Thomas, P. and Kerr, D., 2005. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care, 28, 1801-1802.
  • Richardson, T., Thomas, P., Ryder, J. and Kerr, D., 2005. Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. Diabetes Care, 28, 1316-1320.
  • Kerr, D. and Everett, J., 2005. Coffee, diabetes and insulin sensitivity. Diabetologia, 48, 1418.
  • Kerr, D., 2005. Uses of error: as fit as a butcher's dog. The Lancet, 365, 1981.
  • Kerr, D., 2005. Diabetes and alcohol. Diabetes Digest, 4, 72.
  • Kerr, D., 2005. Inpatient insulin: keeping an eye on intensiveness and intricacy. Diabetes Digest, 4, 144.
  • Kerr, D., 2005. Cancer, diabetes and metformin. Diabetes Digest, 4, 212.
  • Everett, J. and Kerr, D., 2005. Attendance failures in diabetes clinic (Letter). Practical Diabetes International, 16, 2.
  • Knott, J., Cavan, D.A. and Kerr, D., 2005. Transfer of a diabetes education program to primary care. Journal of Diabetes Nursing, 9, 373-376.
  • Everett, J. and Kerr, D., 2005. Measuring the impact of type I diabetes from the patient's perspective. Journal of Diabetes Nursing, 9, 186-190.
  • Trowbridge, S. and Kerr, D., 2005. Diabetes vignette: opening Pandora's box: home assessments for people with diabetes are revealing. Practical Diabetes International, 22, 32.
  • Kerr, D., 2005. Diabetes care in 2005: what’s it all about? Diabetes Digest, 4, 4.
  • Kar, P.S., Meredith, S., Crick, M. and Kerr, D., 2004. A case of bilateral retinal vein occlusion. Practical Diabetes International, 21 (5).
  • Richardson, T., Rozkovec, A., Thomas, P., Ryder, J., Meckes, C. and Kerr, D., 2004. Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. DIABETES CARE, 27 (5), 1127-1131.
  • James, J., Thomas, P., Cavan, D.A. and Kerr, D., 2004. Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. British Medical Journal, 328, 1236-1240.
  • Everett, J. and Kerr, D., 2004. Earning insulin pump therapy. Practical Diabetes International, 21, 173-174.
  • Richardson, T. and Kerr, D., 2004. Acute hypoglycaemia: diagnostic criteria, investigation and management for the emergency physician. Acute Medicine, 3, 47-52.
  • Sharman, D., Richardson, T. and Kerr, D., 2004. Old people, feet and too much sugar - a terrible trio. CME Geriatric Medicine, 6, 73-79.
  • Richardson, T., Rozkovec, A., Thomas, P., Ryder, J., Meckes, C. and Kerr, D., 2004. Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. Diabetes Care, 27, 1127-1131.
  • Cheyne, E.H., Sherwin, R.S., Lunt, M.J., Cavan, D.A., Thomas, P. and Kerr, D., 2004. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes. Diabetic Medicine, 21, 230-237.
  • James, J. and Kerr, D., 2004. Prevention of childhood obesity by reducing soft drinks. International Journal of Obesity, 29, S54-S57.
  • Kerr, D., 2004. If it does what it says on the tin. Diabetes Digest, 3, 210.
  • Kerr, D., 2004. A severe case of doing well. Diabetes Digest, 3, 72.
  • Kerr, D., 2004. Try now and analyse later with home glucose testing. Diabetes Digest, 3, 142.
  • Kerr, D., 2004. Diabetes and old age. Who cares? Diabetes Digest, 3, 1.
  • Kar, P.S., Meredith, S., Crick, M.D. and Kerr, D., 2004. Diabetes vignette: a case of bilateral retinal vein occlusion. Practical Diabetes International, 21, 186a.
  • Avery, L., Kerr, D. et al., 2004. British Diabetic Association guidelines on genetic and immune screening for Type 1 diabetes mellitus. Diabetic Medicine, 15, 643.
  • Owens, D., Barnett, A.H., Pickup, J., Kerr, D., Bushby, P., Hicks, D., Gadsby, R. and Frier, B., 2004. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary Care, 6, 8-16.
  • Kerr, D., Cavan, D.A. and Everett, J., 2004. Diabetes - whats in a name? (Letter). Diabetic Medicine, 15, 619.
  • Richardson, T. and Kerr, D., 2004. Modern aspects of diabetes monitoring. Postgraduate Doctor Africa, 26, 80-84.
  • Kerr, D., 2003. Of Struldbruggs, sugar, and gatekeepers: a tale of our times. British Medical Journal, 327, 1451.
  • James, J., Thomas, P. and Kerr, D., 2003. Letter: Waist Circumference, A Problem all Round (Rapid Response). British Medical Journal.
  • Kerr, D., 2003. Involving patients can work in home blood glucose testing (Letter). British Medical Journal, 326, 103.
  • Everett, J., Jenkins, E.J., Kerr, D. and Cavan, D.A., 2003. Implementation of an effective outpatient intensive education programme for patients with type 1 diabetes. Practical Diabetes International, 20, 51-55.
  • Trowbridge, S., Cavan, D.A. and Kerr, D., 2003. Running a nurse-led hypertension clinic to empower patients and achieve blood pressure targets. Practical Diabetes International, 20, 255-256.
  • Richardson, T. and Kerr, D., 2003. Obesity in type 2 diabetes – local experience in a district general hospital. British Journal of Diabetes and Vascular Disease, 3, 49-52.
  • Plougmann, S., Hejlesen, O.K., Turner, B., Kerr, D. and Cavan, D.A., 2003. The effect of alcohol on blood glucose in Type 1 diabetes—metabolic modelling and integration in a decision support system. International Journal of Medical Informatics, 70, 337-344.
  • Watson, J.M., Sherwin, R.S., Deary, I.A., Scott, L. and Kerr, D., 2003. Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clinical Science, 104, 447-454.
  • Richardson, T. and Kerr, D., 2003. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. American Journal of Clinical Dermatology, 4, 661-667.
  • Kerr, D., Trowbridge, S. and Allen, S.C., 2003. Guideline, targets and protocols. Look before you leap! British Medical Journal, 326, 353.
  • Kerr, D. and Everett, J., 2003. Modern insulin pump therapy. Modern Diabetes Management, 4, 10-12.
  • Kerr, D. and Everett, J., 2003. Assessment of reduced awareness of hypoglycaemia. Journal of Diabetes Nursing, 7, 130-133.
  • Kerr, D., 2003. UK diabetes care in 2003: a view from outer space. Diabetes Digest, 2, 234.
  • Kerr, D., 2003. Diabetology is a wonderful job. Diabetes Digest, 2, 6.
  • Kerr, D., 2003. Moving the microscope – preventing heart disease in type 1 diabetes. Diabetes Digest, 2, 82.
  • Kerr, D., 2003. How do we define the expert patient? Diabetes Digest, 3, 159.
  • Kerr, D. and James, J., 2002. Nutrition, physical activity, and obesity (Letter). The Lancet, 360, 1249.
  • Summers, J.B., Kaminski, J.M., Kerr, D., James, J., Das, U.N., Meguid, M.M. and Jacobson, M.F., 2002. Nutrition, physical activity, and obesity [1] (multiple letters). Lancet, 360 (9341), 1249-1250.
  • Kerr, D., 2002. Ethics and money are not good bedfellows (Letter). British Medical Journal, 324, 975.
  • Kerr, D., 2002. Fifth revision of Declaration of Helsinki - Ethics and money are not good bedfellows. BRITISH MEDICAL JOURNAL, 324 (7343), 975-976.
  • Lunt, M.J., Hanrahan, A., Kerr, D. and Jenkinson, D.F., 2002. Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke. Physiological Measurement, 23, 375-383.
  • Cheyne, E.H. and Kerr, D., 2002. Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes/Metabolism Research and Reviews, 18, S43-S48.
  • Flanagan, D.E.H., Pratt, E., Murphy, J., Vaile, J.C., Petley, G.W., Godsland, I.F. and Kerr, D., 2002. Alcohol consumption alters insulin secretion and cardiac autonomic activity. European Journal of Clinical Investigation, 32, 187-192.
  • Ward, A., Watson, J.M., Wood, P., Dunne, C. and Kerr, D., 2002. Glucocorticoid epidural for sciatica: metabolic and endocrine sequelae. Rheumatology, 41, 68-71.
  • Kerr, D., Hamilton, P. and Cavan, D.A., 2002. Preventing glycaemic excursions in diabetic patients requiring percutaneous endoscopic gastrostomy (PEG) feeding after a stroke. Diabetic Medicine, 19, 1006-1008.
  • Cheyne, E.H., Cavan, D.A. and Kerr, D., 2002. Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technology & Therapeutics, 4, 607-613.
  • Watson, J., Deary, I.A. and Kerr, D., 2002. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. British Journal of Clinical Pharmacology, 54, 400-406.
  • Everett, J. and Kerr, D., 2002. BGAT, BINGO or BASH - what's in a name? Practical Diabetes International, 19, 275.
  • Kerr, D., Gillam, E., Ryder, J., Trowbridge, S., Cavan, D.A. and Thomas, P., 2002. An Eastern art form for a Western disease: randomised controlled trial of yoga in patients with poorly controlled insulin-treated diabetes. Practical Diabetes International, 19, 164-166.
  • Kerr, D., Nicholls, H. and Cavan, D.A., 2002. The lost tribes in diabetes. Diabetic Medicine, 19, 703.
  • Richardson, T., Kentish, J. and Kerr, D., 2002. Something old, something new… - novel treatments for diabetes in the elderly. CME Geriatric Medicine, 4, 53-57.
  • Richardson, T. and Kerr, D., 2002. Digital imaging for the follow-up of patients with established diabetic retinopathy. Practical Diabetes International, 19, 15.
  • Murphy, J., Best, C., Cavan, D.A. and Kerr, D., 2002. Nurse/podiatrist-led clinic for patients with non-ulcerated painful neuropathy. Practical Diabetes International, 19, 140.
  • Kerr, D., 2002. NSF Standards – so good so far. Diabetes Digest, Suppl, A2.
  • Kerr, D., 2002. Dreams could be sweeter. Personalising intensive insulin therapy can be achieved by continuous glucose monitoring. Capital Doctor, 14, 20-21.
  • Richardson, T. and Kerr, D., 2002. Modern aspects of diabetes monitoring. Postgraduate Doctor Middle East, 25, 157-160.
  • Kerr, D. and Everett, J., 2002. Continuous subcutaneous insulin infusion (CSII), a UK perspective. Infusystems International, 1, 2-3.
  • Kerr, D., 2002. Food for thought. Diabetes Digest, 1, 134.
  • Kerr, D., 2002. Type 2 or not type 2? Should that be the question? Diabetes and Primary Care, 4, 5.
  • Kerr, D., 2002. Preventing diabetes – part of the job description or pure empowerment? Diabetes Digest, 4, 198.
  • Kerr, D., 2002. Monkey business. Diabetes Digest, 5, 266.
  • Kerr, D., 2002. Exciting times ahead. Diabetes Digest, 6.
  • Plougmann, S., Hejlesen, O.K., Turner, B., Kerr, D. and Cavan, D.A., 2002. Modelling the effect of alcohol in Type 1 diabetes. Studies in health technology and informatics, 90, 66-71.
  • Abi-Saab, W.M., Kerr, D. et al., 2002. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. Journal of Cerebral Blood Flow & Metabolism, 22, 271-279.
  • James, J., Thomas, P. and Kerr, D., 2002. Childhood obesity: a big problem for small people. Diabetes and Primary Care, 4, 75-79.
  • Kerr, D., 2001. Continuous blood glucose monitoring: Detection and prevention of hypoglycaemia. International Journal of Clinical Practice, 43-46.
  • Kerr, D., Cheyne, E.H., Weiss, M., Ryder, J. and Cavan, D.A., 2001. Accuracy of MiniMed continuous glucose monitoring system during hypoglycaemia. DIABETOLOGIA, 44, A239.
  • Turner, B., Hejlesen, O.K., Kerr, D. and Cavan, D.A., 2001. Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model. Diabetes Technology & Therapeutics, 3, 99-109.
  • Cavan, D.A., Hamilton, P., Everett, J. and Kerr, D., 2001. Reducing hospital inpatient length of stay for patients with diabetes. Diabetic Medicine, 18, 162-164.
  • Turner, B., Jenkins, E.J., Kerr, D., Sherwin, R.S. and Cavan, D.A., 2001. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care, 24, 1888-1893.
  • Pratt, E., Miles, P. and Kerr, D., 2001. Localized insulin allergy treated with continuous subcutaneous insulin. Diabetic Medicine, 18, 515-516.
  • Kerr, D., 2001. Continuous blood glucose monitoring: detection and prevention of hypoglycaemia. International Journal of Clinical Practice, S123, 43-46.
  • Khattab, A.D., Ali, I.S., Dils, R., Kerr, D., Jenkinson, D.F., Allen, S. and Rana, M., 2001. Nitric oxide synthase and carotid artery plaque morphology. Atherosclerosis Supplements, 2, 103.
  • Khattab, A.D., Ali, I.S., Dils, R., Kerr, D., Jenkinson, D.F., Allen, S.C. and Rana, M., 2001. Pro-matrix metalloproteinases (pro-MMP-3) and atherosclerotic carotid artery plaque. Biochemical Society Transactions, 29, 72.
  • Richardson, T. and Kerr, D., 2001. Insulin pump therapy for diabetes – a revival of interest. Modern Diabetes Management, 2, 8-11.
  • Everett, J. and Kerr, D., 2001. Measuring quality of life in diabetes. Journal of Diabetes Nursing, 5, 53-55.
  • Kerr, D., 2001. National service framework – hope, hype or hell? Diabetes Digest, 1 (Supp), A2.
  • Kerr, D., 2001. National service framework: spare a thought for the troops! Diabetes Digest, 2 (Supp), A2.
  • Owen, G., Watson, J.M., McGown, A., Sharma, S., Deary, I.A., Kerr, D. and Barrett, G., 2001. Influence of hypoglycaemia, with or without caffeine ingestion, on visual sensation and performance. Clinical Science, 100, 619-626.
  • Kerr, D., 2001. Star qualities or star wars? Diabetes Digest, 2, 70.
  • Cheyne, E., Everett, J., Cavan, D. and Kerr, D., 2000. Making sense of type 1 diabetes. Unrecognised hypoglyceamia during continuous glucose sensing. DIABETOLOGIA, 43, A206.
  • Sharman, D., Cheyne, E., Cavan, D. and Kerr, D., 2000. Safe driving and diabetic complications, myth or reality? DIABETOLOGIA, 43, A235.
  • Kerr, D. and Cavan, D.A., 2000. Time to pass the monkey (Letter). Hospital Doctor.
  • Watson, J.M., Lunt, M.J., Morris, S., Weiss, M.J., Hussey, D. and Kerr, D., 2000. Reversal of caffeine withdrawal by ingestion of a soft beverage. Pharmacol Biochem Behav, 66 (1), 15-18.
  • Kerr, D., 2000. Dull journals. Lancet, 355 (9208), 1020.
  • Owen, G., Watson, J., McGown, A., Sharma, S., Deary, I., Kerr, D., Casey, A. and Barrett, G., 2000. The effects of hypoglycaemia, with and without caffeine ingestion, on visual sensation and performance. JOURNAL OF PHYSIOLOGY-LONDON, 523, 225P.
  • Begley, J.P. and Kerr, D., 2000. Diabetes and lipids - A conundrum [1]. Diabetic Medicine, 17 (8), 623-624.
  • Owen, G., Barrett, G., Watson, J. and Kerr, D., 2000. The effects of caffeine ingestion on visual sensation during hypoglycaemia. JOURNAL OF PSYCHOPHYSIOLOGY, 14 (3), 190.
  • Ege, B.M., Hejlesen, O.K., Larsen, O.V., Moller, K., Jennings, B., Kerr, D. and Cavan, D.A., 2000. Screening for diabetic retinopathy using computer based image analysis and statistical classification. Computer Methods and Programs in Biomedicine, 62, 165-175.
  • Lee, B., Cavan, D.A. and Kerr, D., 2000. Restructuring, rationing or researching diabetes care. Practical Diabetes International, 17, 115-117.
  • Lunt, M.J., Jenkinson, D.F. and Kerr, D., 2000. Transcranial Doppler blood velocity measurement-the effect of changes in velocity profile. Ultrasound in Medicine and Biology, 26, 1145-1151.
  • Browne, D.L., Avery, L., Turner, B., Kerr, D. and Cavan, D.A., 2000. What do patients with diabetes know about their tablets? Diabetic Medicine, 17, 528-531.
  • Watson, J.M., Jenkins, E.J., Hamilton, P., Lunt, M.J. and Kerr, D., 2000. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care, 23, 455-459.
  • Flanagan, D.E.H., Watson, J.M., Everett, J., Cavan, D.A. and Kerr, D., 2000. Driving and insulin - consensus, conflict or confusion? Diabetic Medicine, 17, 316-320.
  • Watson, J.M., Lunt, M.J., Morris, S., Weiss, M.J., Hussey, D. and Kerr, D., 2000. Reversal of caffeine withdrawal by ingestion of a soft beverage. Pharmacology Biochemistry and Behavior, 66, 1518.
  • Kerr, D., 2000. Dull journals (Letter). The Lancet, 355, 1020.
  • Begley, J.P. and Kerr, D., 2000. Lipids and diabetes – a conundrum? (Letter). Diabetic Medicine, 17, 623-624.
  • Sharman, D. and Kerr, D., 2000. Practical management of foot ulceration associated with diabetic peripheral neuropathy. The Diabetic Foot, 3, 49-54.
  • Everett, J. and Kerr, D., 2000. Insulin pumps revisited. Journal of Diabetes Nursing, 4, 44-51.
  • Miles, P. and Kerr, D., 2000. Very low calorie diets in diabetes. The Bournemouth experience. Journal of Diabetes Nursing, 4, 108-111.
  • Kerr, D. and Richardson, T., 2000. The diabetic foot at the crossroads vanguard or oblivion? The Diabetic Foot, 3, 70-71.
  • Kerr, D., 2000. And now for something completely different. Diabetes Digest, 1, 6.
  • Sharman, D., O'Halloran, D., Best, C., Cavan, D. and Kerr, D., 1999. Laterality of diabetic foot ulceration fact or fiction? DIABETOLOGIA, 42, A312.
  • Kerr, D. and Everett, J., 1999. Role of insulin in the management of diabetes. Prescriber, June 19, 45-49.
  • Kerr, D. and Cavan, D., 1999. Clinical trials and new products . Diabetes Metab Res Rev, 15 (3), 228-231.
  • Kerr, D. and Cavan, D., 1999. The virtual diabetic patient: AIDA on-line. http://www.shodor. Org/aida . Diabetes Metab Res Rev, 15 (3), 226.
  • Kerr, D., 1999. Political correctness is behind proposed appraisal system (Letter). British Medical Journal, 318, 1013.
  • Kerr, D., 1999. Is appraisal the answer to ‘dodgy docs’? Employing Medical and Dental Staff, 15, 10-11.
  • Ward, A. and Kerr, D., 1999. Diabetes, alcohol and hypoglycaemia. Medical Council on Alcoholism, 18, 1-2.
  • Khattab, A.D., Ali, I.S., Dils, R., Darke, S.G., Kerr, D. and Rana, M., 1999. Serum lipid profile and peripheral arterial disease in diabetic patients. Journal of Endocrinology, 160, 19.
  • Kerr, D. and Cavan, D.A., 1999. Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist. Diabetes/Metabolism Research and Reviews, 15, 219-225.
  • Watson, J. and Kerr, D., 1999. The best defense against hypoglycemia is to recognize it: is caffeine useful? Diabetes Technology & Therapeutics, 1, 193-200.
  • Watson, J.M., Weiss, M.J., Lunt, M.J., Cavan, D.A. and Kerr, D., 1998. Does the brain become tolerant to sustained caffeine use? Implications for treatment hypoglycaemia unawareness. DIABETOLOGIA, 41, A241.
  • Kerr, D., Cavan, D.A. and Everett, J., 1998. Diabetes - What's in a name? [1]. Diabetic Medicine, 15 (7), 619.
  • Kerr, D., Cavan, D.A., Jennings, B., Dunnington, C., Gold, D. and Crick, M.D., 1998. Beyond retinal screening: digital imaging in the assessment and follow-up of patients with diabetic retinopathy. Diabetic Medicine, 15, 878-882.
  • Khattab, A.D., Ali, I.S., Bowley, J., Dils, R., Darke, S.G., Kerr, D. and Rana, M., 1998. Protein glycosylation and peripheral vascular disease in diabetic patients. Biochemical Society Transactions, 26, 118.
  • Flanagan, D.E.H., Wood, P., Sherwin, R.S., Debrah, K. and Kerr, D., 1998. Gin and tonic and reactive hypoglycemia: what is important–the gin, the tonic, or both? Journal of Clinical Endocrinology & Metabolism, 83, 796-800.
  • Flanagan, D.E.H., Cole, C., Crick, M.D. and Kerr, D., 1998. Blurred vision and high blood pressure in a young woman. Postgraduate Medical Journal, 74, 614-615.
  • Everett, J. and Kerr, D., 1998. Nurse-led management of newly diagnosed type-2 diabetes. Journal of Diabetes Nursing, 2, 12-21.
  • Everett, J. and Kerr, D., 1998. A picture of the impact of newly diagnosed type 2 diabetes. Journal of Diabetes Nursing, 2, 170-175.
  • Everett, J. and Kerr, D., 1998. Managing the hypoglycaemic driver. Journal of Diabetes Nursing, 1, 108-112.
  • Miles, P., Everett, J., Murphy, J. and Kerr, D., 1997. Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: patient survey after randomised crossover trial. British Medical Journal, 315, 348-349.
  • Tiarks, C., Fuller, J. and Kerr, D., 1997. Loss of diabetic control in an elderly patient. Practitioner, 241 (1577), 431-438.
  • Everett, J., Cavan, D. and Kerr, D., 1997. Is sweating a useful indicator of nocturnal hypoglycaemia? DIABETOLOGIA, 40, 1291.
  • Watson, J., Lunt, M., Murphy, J., Jenkins, E. and Kerr, D., 1997. Physiological and psychological effects of acute caffeine withdrawal. DIABETOLOGIA, 40, 1533.
  • Jenkins, E., Knott, J., Scott, L. and Kerr, D., 1997. Setting diabetes dietary standards - is it worth the effort? DIABETOLOGIA, 40, 1537.
  • Everett, J., Jenkins, E., Miles, P., Cavan, D. and Kerr, D., 1997. Long term benefits of immediate, intensive education at diagnosis of NIDDM. DIABETOLOGIA, 40, 41.
  • Ward, A. and Kerr, D., 1997. Top 100. Diabetes. General Practitioner, May 23, 2-4.
  • Ward, A. and Kerr, D., 1997. Treatment options for young adult diabetics. Family Medicine, 1, 28-30.
  • Thomas, M., Sherwin, R.S., Murphy, J. and Kerr, D., 1997. Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes, 46, 829-833.
  • Flanagan, D., Sherwin, R., Murphy, J., Wood, P. and Kerr, D., 1996. Gin and tonic and reactive hypoglycaemia. What is important - gin, tonic or both? DIABETOLOGIA, 39, 826.
  • Frier, B., Deary, I.A., Macdonald, I.A., Kerr, D. and Fisher, B.M., 1996. Experimentally induced hypoglycaemia (Letter). The Lancet, 348, 61.
  • Taylor, M. and Kerr, D., 1996. Diabetes control and complications: a coming of AGE. The Lancet, 347, 485.
  • Debrah, K., Murphy, J., Kerr, D. and Sherwin, R.S., 1996. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes. The Lancet, 347, 19-24.
  • Flanagan, D.E.H., Creasy, T., Chataway, F. and Kerr, D., 1996. Caval umbrella causing obstructive uropathy. Postgraduate Medical Journal, 72, 235-237.
  • Kerr, D., 1996. Caffeine and the perception of hypoglycaemia. Biomedicine and Pharmacotherapy, 50 (6-7), 320.
  • Flanagan, D. and Kerr, D., 1996. Recurrent hypoglycaemia and long-standing brittle diabetes. Endocrinology and Metabolism, Supplement, 3 (1), 67-69.
  • Kerr, D., 1996. Non-insulin dependent diabetes - 10 questions answered. Pulse, 12, 93-96.
  • JENKINS, E., EVERETT, J., MILES, P. and KERR, D., 1995. BENEFITS OF NUTRITION FOCUSED CARE FROM DIAGNOSIS OF NIDDM. DIABETES, 44, A236.
  • Debrah, K., Haigh, R., Sherwin, R.S., Murphy, J. and Kerr, D., 1995. Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clinical Science, 89, 475-480.
  • Kerr, D. and Haigh, R., 1994. Intensive diabetes treatment: a new deal for old people? Age and Ageing, 23, 89-90.
  • Kerr, D., Sherwin, R.S., Pavalkis, F., Fayad, P.B., Sikorski, L., Rife, F., Tamborlane, W.V. and During, M.J., 1993. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Annals of Internal Medicine, 119, 799-804.
  • Kerr, D., Tamborlane, W.V., Rife, F. and Sherwin, R.S., 1993. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. Journal of Clinical Investigation, 91, 141-147.
  • Kerr, D., Diamond, M.P., Tamborlane, W.V., Kerr, S. and Sherwin, R.S., 1993. Influence of counterregulatory hormones, independently of hypoglycaemia, on cognitive function, warning symptoms and glucose kinetics. Clinical Science, 85, 197-202.
  • Kerr, D., Stanley, J.C., Barron, M., Thomas, R., Leatherdale, B.A. and Pickard, J., 1993. Symmetry of cerebral blood flow and cognitive responses to hypoglycaemia in humans. Diabetologia, 36, 73-78.
  • Rennert, N.J., Boulware, S.D., Kerr, D., Caprio, S., Tamborlane, W.V. and Sherwin, R.S., 1993. Metabolic effects of rhIGF-1 in normal human subjects. Advances in Experimental Medicine and Biology, 343, 311-318.
  • Kerr, D. and Haigh, R., 1993. Leader: Coffee and diabetes. Practical Diabetes International, 10, 128.
  • Allen, N.H.P., Kerr, D., Smythe, P.J., Martin, N., Osola, K. and Thompson, C., 1992. Insulin sensitivity after phototherapy for seasonal affective disorder (Letter). The Lancet, 339, 1065-1066.
  • Jones, R.B., Gregory, R., Jones, E.W., Kerr, D., Allison, S.P., McLeod, A., Titterington, D.M. and Hedley, A.J., 1992. The quality and relevance of peripheral neuropathy data on a diabetic clinical information system. Diabetic Medicine, 9, 934-937.
  • Egger, M., Davey Smith, G., Teuscher, A., Kerr, D., Maggs, D., Moriarty, T., Patrick, A.W. and Williams, G., 1991. Hypoglycaemia awareness and human insulin (Letter). The Lancet, 338, 950-951.
  • Kerr, D., Reza, M., Smith, N. and Leatherdale, B.A., 1991. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes, 40, 1057-1062.
  • Kerr, D., Macdonald, I.A. and Tattersall, R.B., 1991. Patients with type-1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabetic Medicine, 8, 123-128.
  • Tattersall, R.B., Gregory, R., Selby, C., Kerr, D. and Heller, S.R., 1990. Course of brittle diabetes: 12 year follow up. British Medical Journal, 302, 1240-1243.
  • Kerr, D., Macdonald, I.A., Heller, S.R. and Tattersall, R.B., 1990. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with Type 1 (insulin-dependent) diabetes. Diabetologia, 33, 216-221.
  • Kerr, D., Macdonald, I.A., Heller, S.R. and Tattersall, R.B., 1990. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. British Journal of Clinical Pharmacology, 29, 685-693.
  • Kerr, D., Skinner, D.W., Hosking, D.J., Bradley, P.J. and Salama, F.D., 1990. Maintenance of serum calcium after total thyroparathyroidectomy. European Journal of Surgical Oncology, 16, 436-442.
  • Stone, M.D., Hawthorne, M.B., Kerr, D., Webster, G. and Hosking, D.J., 1990. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate. Journal of Bone and Mineral Research, 5, 1231-1235.
  • Kerr, D., Macdonald, I.A., Hillier, J. and Tattersall, R.B., 1989. Adrenaline response to hypoglycaemia and insulin species (Letter). The Lancet, 333, 836.
  • Kerr, D., Macdonald, I.A. and Tattersall, R.B., 1989. Influence of duration of hypoglycemia on the hormonal counterregulatory response in normal subjects. Journal of Clinical Endocrinology and Metabolism, 68, 1118-1122.
  • Kerr, D., Macdonald, I.A. and Tattersall, R.B., 1989. Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones. Diabetologia, 32, 249-254.
  • Kerr, D. and Kerr, S., 1988. Diabetic camps for children - effects on control and hypoglycaemia. Practical Diabetes International, 5, 74-76.
  • Hosking, D.J. and Kerr, D., 1988. Mechanisms of parathyroid hormone resistance in pseudohypoparathyroidism. Clinical Science, 74, 561-566.
  • Kerr, D. and Everett, J., 1988. Changing from porcine to human insulin. Drugs, 47, 286-296.
  • Kerr, D. and Hosking, D.J., 1987. Pseudohypoparathyroidism: clinical Expression of PTH resistance. QJM, 65, 889-894.
  • Kerr, D., Hooper, W.L. and Jones, D.M., 1986. A rare case of meningitis due to Neisseria meningitidis group 29E. Journal of Infection, 13, 147-149.
  • Kerr, D., 1986. Cuba Libre (Letter). British Medical Journal, 293, 29.

Chapters

  • Nolan, J.J., Danne, T., Diamant, M., Hood, G., Kautzky-Willer, A., Kerr, D., Mitrakou, A., Nilsson, P.A. and Pacini, G., 2010. Clinical science and care incorporating the development of a European Platform for Clinical Research in Diabetes (EPCRD). Roadmap for diabetes research in Europe. DIAMAP, 73-114.
  • Kerr, D., 2007. Counterregulatory deficiences in diabetes. In: Frier, B.M. and Fisher, M., eds. Hypoglycaemia in clinical disease. Chichester: Wiley, 121-141.
  • Richardson, T. and Kerr, D., 2007. Moderators and management of hypoglycaemia. In: Frier, B.M. and Fisher, M., eds. Hypoglycaemia in clinical disease. Chichester: Wiley, 100-120.
  • Cheyne, E.H. and Kerr, D., 2001. Future prospects in insulin therapy. In: Barnett, A.H., ed. Insulin made easy. London: Medical Education Partnership, 90-100.
  • Kerr, D., 1999. Counterregulatory deficiences in diabetes. In: Frier, B.M. and Fisher, B.M., eds. Hypoglycaemia in clinical diabetes. Chichester: J Wiley, 89-110.
  • Kerr, D., 1998. Diabetic ketoacidosis and surgery and diabetes. In: Dunnill, R. and Colvin, P., eds. Clinical and resuscitative data : a compendium of acute medical data. Oxford: Blackwell Science, 139-143.
  • Kerr, D., 1993. Drugs and alcohol. In: Frier, B.M. and Fisher, M., eds. Hypoglycaemia and diabetes : clinical and physiological aspects. London: Edward Arnold, 328-336.
  • Kerr, D. and Tattersall, R.B., 1988. Diabetes and old age. In: Alberti, K.G.M.M. and Krall, L.P., eds. The Diabetes Annual. Amsterdam: Elsevier, 222-234.

Conferences

  • Gribble, L., Gouni, R., Eriksson, M., Boyle, J., Kerr, D. and Coppini, D., 2010. A double-blind randomised study comparing the effects of pregabalin, duloxetine and amitryptiline on aspects of neuropathic pain, mood and sleep in diabetic subjects with painful neuropathy. S16-S17.
  • Rana, O., Zouwail, S., Coppini, D.V., Senior, R., Begley, J., Kerr, D., Byrne, C.D. and Greaves, K., 2009. The Effect of Insulin-induced Hypoglycaemia an Myocardial Blood Flow in Patients With Type 1 Diabetes Mellitus. S368.
  • Purandare, L., Hickish, T., Astras, G., Penfold, S., Thomas, F. and Kerr, D., 2009. Impaired glucose tolerance in non-diabetic women during adjuvant chemotherapy for breast cancer. 309.
  • Eriksson, M.E.V., Gouni, R., Gribble, L.C., Coppini, D.D., Kerr, D. and Boyle, J., 2008. Investigation of the impact of painful diabetic peripheral neuropathy on sleep quality and sleep architecture in type 1 and 2 diabetic patients using polysomnography. S507.
  • Eriksson, M.E., Gribble, L.C., Gouni, R., Kerr, D., Coppini, D.V. and Boyle, J., 2008. Impact of painful diabetic peripheral neuropathy on sleep architecture using polysomnography. A299.
  • Boyle, J., Mills, S.L., Gouni, R., Coppini, D.V., Kerr, D. and Eriksson, M.E., 2008. Painful diabetic peripheral neuropathy: Assessment of quality of sleep and sleep continuity. A299.
  • Gribble, L., Korimbocus, A., Middleton, B., Gouni, R., Kerr, D., Coppini, D.V. and Boyle, J., 2008. Sleep in painful diabetic peripheral neuropathy: Subjective measures and actigraphy analysis. A299.
  • Hart, T., Kerr, D. and Begley, J., 2007. Influence of lifestyle change on Glucagon-Like Peptide-1 in new onset type 2 diabetes. Pilot study. S339.
  • Newman, S., Kerr, D. et al., 2007. RCT of continuous glucose monitoring devices on HbA(1C) - The MITRE study. S115-S116.
  • Cooke, D., Steed, L., Hurel, S.J., Nunn, A., Ahlquist, J., Weaver, J., Kerr, D., Barnard, M. and Newman, S., 2007. Use and acceptability of two minimally invasive continuous blood glucose monitors. S418-S419.
  • Bolinder, J., Deiss, D., Riveline, J., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D. and Phillip, M., 2005. Guardian (R) RT Continuous Glucose Monitoring System with real time glucose values and alarms functions: a new tool for improving glucose control in patients with type 1 diabetes mellitus? A49.
  • Fegan, G., Hamliton, P. and Kerr, D., 2004. A prospective study to assess the clinical application of glucose monitoring in hospitalised patients with Type 2 diabetes. A320.
  • Bolli, G.B., Capani, F., Kerr, D., Thomas, R., Torlone, E., Selam, J.L., Sola-Gazagnes, A. and Vitacolonna, E., 2004. Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study. A301.
  • Hoogma, R.P.L., Kerr, D. et al., 2004. Comparison of continuous subcutaneous insulin infusion (CSII) vs. multiple daily insulin injections (MDI) in regard to metabolic control. Results of the 5-Nations trial. A32-A33.
  • James, J., Thomas, P. and Kerr, D., 2004. Longitudinal results from CHOPPS (Christchurch Obesity Prevention Project in Schools). S33.
  • James, J., Thomas, P., Cavan, D.A. and Kerr, D., 2004. Longitudinal Results from CHOPPS (Christchurch Obesity Prevention Project in Schools). In: 13th European Congress on Obesity 26-29 May 2004 Prague, Czech Republic.
  • James, J., Thomas, P., Cavan, D.A. and Kerr, D., 2004. Longitudinal Results from CHOPPS (Christchurch Obesity Prevention Project in Schools). In: 40th Annual Meeting of the European Association for the Study of Diabetes 5-9 September 2004 Munich, Germany.
  • Everett, J.D., Jenkins, E., Kerr, D. and Cavan, D.A., 2003. Using computer modelling to enhance structured education for people with Type 1 diabetes. A88.
  • James, J., Thomas, P., Cavan, D.A. and Kerr, D., 2003. CHOPPS: The Christchurch Obesity Prevention Programme in Schools. In: IDF-Paris 2003: 18th International Diabetes Federation Congress 24-29 August 2003 Paris, France.
  • James, J., Thomas, P. and Kerr, D., 2003. Apples, not Pears. In: Diabetes UK Meeting 19-21 March 2003 Glasgow, Scotland.
  • Cheyne, E.H., Weiss, M.J., Lunt, M.J., Thomas, P., Cavan, D.A. and Kerr, D., 2001. Influence of Combination of Mild Hypoglycemia and Modest Alcohol Ingestion on Cognitive Performance in Type 1 Diabetes. In: American Diabetes Association Conference 2001.
  • Trowbridge, S., Kerr, D., Cavan, D.A., Weiss, M.J. and Thomas, P., 2001. Hitting the target through patient empowerment. Randomised control trial of self monitoring and self adjustment of antihypertensive therapy in type 2 diabetes. In: American Diabetes Association Conference 2001.

Reports

Public Engagement & Outreach Activities

  • http://www.voyagemd.com/
  • http://www.excarbs.com/
The data on this page was last updated at 04:08 on December 12, 2018.